PRINCETON, N.J., Sept. 16, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today provided a regulatory update on DrugSorb™-ATR. On August 20,...
CytoSorbents Provides DrugSorb-ATR Regulatory Update
Seeking Alpha / 12 hours ago 1 Views
Comments